Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Catalyst Biosciences Inc (CBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7495
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti-complement. Its pipeline products include factor VIIa marzeptacog alfa, for the treatment of individuals with hemophilia A and B; factor IX CB 2679d, for the treatment of hemophilia B; factor Xa variants, currently in research phase; and anti-C3: CB 2782, for treating dry age-related macular degeneration, ischemia-reperfusion injuries and inflammatory retinal diseases. The company partners with various international pharmaceutical companies to develop and commercialize its engineered human proteases. Catalyst Biosciences is headquartered in South San Francisco, California, the US.

Catalyst Biosciences Inc (CBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Catalyst Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Catalyst Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Equity Offering 13
Catalyst Biosciences Raises USD115 Million in Public Offering of Shares 13
Catalyst Biosciences Raises USD10.5 Million in Public Offering of Shares 15
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 17
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 18
Debt Offering 19
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 19
Catalyst Biosciences Inc – Key Competitors 20
Catalyst Biosciences Inc – Key Employees 21
Catalyst Biosciences Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate Update 23
May 03, 2018: Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update 24
Mar 01, 2018: Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update 26
Nov 02, 2017: Catalyst Biosciences Reports Third Quarter 2017 Operating & Financial Results and Provides Corporate Update 27
May 11, 2017: Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 28
Mar 08, 2017: Catalyst Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 29
Corporate Communications 30
Jul 10, 2018: Catalyst Biosciences Names Grant Blouse as Vice President of Translational Research 30
Dec 14, 2017: Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors 31
Nov 28, 2017: Catalyst Biosciences Strengthens Clinical Hemophilia Programs with Additions to its Senior Leadership Team 32
Feb 16, 2017: Catalyst Biosciences Announces Promotion of Andrew Hetherington to SVP of Technical Operations 33
Legal and Regulatory 35
Jun 25, 2018: Catalyst Biosciences joins the Russell 2000 index 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Catalyst Biosciences Inc, Medical Equipment, Key Facts, 2017 2
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Catalyst Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Catalyst Biosciences Raises USD115 Million in Public Offering of Shares 13
Catalyst Biosciences Raises USD10.5 Million in Public Offering of Shares 15
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 17
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 18
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 19
Catalyst Biosciences Inc, Key Competitors 20
Catalyst Biosciences Inc, Key Employees 21

List of Figures
Catalyst Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Catalyst Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Catalyst Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kuwait Petroleum Corp:企業の戦略的SWOT分析
    Kuwait Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Omnova Solutions Inc. (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc. (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SoTHERLY Hotels Inc:戦略・SWOT・企業財務分析
    SoTHERLY Hotels Inc - Strategy, SWOT and Corporate Finance Report Summary SoTHERLY Hotels Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Israel Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Israel Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mayo Clinic:企業のM&A・事業提携・投資動向
    Mayo Clinic - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mayo Clinic Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Recordati SpA (REC):製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and …
  • CanBas Co Ltd (4575)-製薬・医療分野:企業M&A・提携分析
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It product under development is CBP501, a modified synthetic peptide enhancing the efficacy of …
  • United Overseas Bank Ltd:戦略・SWOT・企業財務分析
    United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Petrochemical Corporation of Singapore (Private) Ltd:企業の戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key comp …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lea County Electric Cooperative Inc:発電所・企業SWOT分析
    Lea County Electric Cooperative Inc – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Fresh Del Monte Produce Inc.:企業の戦略・SWOT・財務情報
    Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report Summary Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • BankUnited Inc:企業のM&A・事業提携・投資動向
    BankUnited Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BankUnited Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • University of Colorado Technology Transfer Office-医療機器分野:企業M&A・提携分析
    Summary University of Colorado Technology Transfer Office (CU TTO), a subsidiary of University of Colorado (CU) is a technology transfer service provider that provides development and commercialization processes. The university provides services such as intellectual property management, commercializ …
  • Metro Inc.:企業の戦略・SWOT・財務情報
    Metro Inc. - Strategy, SWOT and Corporate Finance Report Summary Metro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sygnis AG (LIO1):医療機器:M&Aディール及び事業提携情報
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆